Shangli Cai

3PUBLICATIONS
13CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Feb 02, 2026
First-line Aumolertinib (EGFR tyrosine kinase inhibitor) plus apatinib (VEGFR inhibitor) versus aumolertinib in EGFR-mutant non-small cell lung cancer patients: a randomized, multicenter, phase II trial.

Fan Zhang, Zhendong Zheng, Hongmei Zhang

|Feb 27, 2025
Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases.

Mei-Mei Zheng, Qing Zhou, Hua-Jun Chen

|Dec 23, 2024
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial.

Jia Zhong, Kailun Fei, Lin Wu

Pageof 1

Frequent Collaborators

2 joint publications

Lin Wu

1 joint publications

Yun Fan

1 joint publications

Mei-Mei Zheng

1 joint publications

Qing Zhou